Crossmark

Individualized transcranial temporal interference stimulation (tTIS) for cognitive impairments and negative symptoms in patients with schizophrenia: a study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12888-025-07158-8

Published Online: 2025-07-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Shuzhe

Chen, Junhao

Wang, Linxuan

Liu, Jingxuan

Wang, Lijun

Sun, Wenjie

Li, Shen

Li, Jie
Funding

Funding for this research was provided by:

Natural Science Foundation of Tianjin Municipality (24JCYBJC01000)
License Information

Text and Data Mining valid from 2025-07-18

Version of Record valid from 2025-07-18
More Information

Article History

Received: 24 June 2025

Accepted: 27 June 2025

First Online: 18 July 2025

Declarations

:

: The protocol was approved by the institutional review board of TMHC on April 29, 2025 (Approval Number: [2025-10]). Additionally, the study has been registered with the Chinese Clinical Trial Registry under the registration number ChiCTR2500102724. All participants will be required to provide written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below